Shares of Marksans Pharma Ltd were trading in the green and 1.8% higher on 30 May after the company’s subsidiary secured marketing approval. The company stated in a stock exchange filing that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) granted market authorisation for the former’s subsidiary Relonchem Ltd Metformin Hydrochloride oral solution in…
UBS was on a selling spree on Friday as the Zurich-based bank and financial services company sold its holding in four stocks through UBS Principal Capital Asia Limited via block deals. The stocks included Concord Biotech, Five Star Business Finance, IIFL Securities and Marksans Pharma and the total share sale aggregated to Rs 480 crore….
Shares of Marksans Pharma Ltd were trading in the green and 2% higher on 28 May after the company announced securing approval from the UK health regulators to market new oral solutions. In its regulatory filing, the company said that its wholly-owned subsidiary Reonchem has received the marketing authorisation from UK MHRA for Levetiracetam Relonchem…